We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$406M
AUM Growth
-$32.3M
Cap. Flow
-$132M
Cap. Flow %
-32.56%
Top 10 Hldgs %
49.27%
Holding
151
New
39
Increased
19
Reduced
25
Closed
51

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.43M
5
AGN
Allergan Inc
AGN
+$6.23M

Top Sells

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$116M
2
GSK icon
GSK
GSK
+$19M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.9M
5
SNY icon
Sanofi
SNY
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Technology 4.07%
3 Consumer Discretionary 3.5%
4 Industrials 2.92%
5 Communication Services 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCYC
26
DELISTED
PHARMACYCLICS INC
PCYC
$4.49M 1.11%
+50,000
New +$4.69M
TW
27
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$4.35M 1.07%
+41,740
New +$4.56M
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
$4.35M 1.07%
105,000
+65,000
+163% +$3.35M
GILD icon
29
Gilead Sciences
GILD
$162B
$4.15M 1.02%
50,000
-44,000
-47% -$3.42M
INCY icon
30
Incyte
INCY
$24.2B
$4.12M 1.02%
73,000
-10,000
-12% -$511K
PTCT icon
31
PTC Therapeutics
PTCT
$5.64B
$3.92M 0.97%
+150,000
New +$3.21M
EPZM
32
DELISTED
Epizyme, Inc
EPZM
$3.52M 0.87%
+113,188
New +$2.67M
CL icon
33
Colgate-Palmolive
CL
$73.1B
$3.26M 0.8%
47,799
-15,000
-24% -$1.01M
AN icon
34
AutoNation
AN
$7.11B
$3.14M 0.77%
+52,600
New +$2.91M
BRCM
35
DELISTED
BROADCOM CORP CL-A
BRCM
$2.94M 0.72%
79,120
-33,380
-30% -$1.09M
CSTE icon
36
Caesarstone
CSTE
$72.3M
$2.92M 0.72%
59,600
+51,770
+661% +$2.63M
AERI
37
DELISTED
Aerie Pharmaceuticals
AERI
$2.73M 0.67%
110,000
-2,500
-2% -$43.3K
TTPH
38
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.67M 0.66%
+9,900
New +$2.12M
AMPE
39
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2.6M 0.64%
1,040
+290
+39% +$592K
RCPT
40
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$2.56M 0.63%
+60,000
New +$2.07M
MGNX icon
41
MacroGenics
MGNX
$235M
$2.41M 0.59%
111,000
+70,000
+171% +$1.47M
EIGR
42
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.4M 0.59%
+333
New +$1.67M
CASC
43
DELISTED
Cascadian Therapeutics, Inc.
CASC
$2.39M 0.59%
123,056
– –
BKNG icon
44
Booking.com
BKNG
$149B
$2.32M 0.57%
48,300
-7,750
-14% -$372K
VNDA icon
45
Vanda Pharmaceuticals
VNDA
$307M
$2.27M 0.56%
140,000
+75,000
+115% +$999K
ATNM icon
46
Actinium Pharmaceuticals
ATNM
$26.3M
$2.17M 0.53%
+10,000
New +$3.33M
AKBA icon
47
Akebia Therapeutics
AKBA
$354M
$2.02M 0.5%
+72,500
New +$1.75M
GILD icon
48
CALL
Gilead Sciences
GILD
$162B
$2.01M 0.49%
2,000
– –
IMMU
49
DELISTED
Immunomedics Inc
IMMU
$2.01M 0.49%
550,000
+250,000
+83% +$918K
TRVN
50
DELISTED
Trevena, Inc.
TRVN
$1.93M 0.47%
546
+146
+37% +$456K
1
2
3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sphera Funds Management held 151 positions worth $406M, down 7.4% from $438M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q2 2014, closing 51 positions and reducing 25 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Shire pic worth $14.1M.

  • Sphera Funds Management's largest Q2 2014 buy was Shire pic: 180,000 shares worth $14.1M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q2 2014 reduction was Summit Financial Group, Inc., cutting an estimated $116M.
  • Sphera Funds Management fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $15.2M.
  • Sphera Funds Management's ten largest holdings make up 49% of its $406M portfolio in Q2 2014.
  • Sphera Funds Management opened 39 new positions and closed 51 in Q2 2014.
  • Sphera Funds Management's portfolio value fell 7.4% quarter-over-quarter to $406M.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.